Table 4.
Median household income before and during multidrug-resistant tuberculosis treatment by experiencing catastrophic costs
| No catastrophic costs (N = 12) | Catastrophic costs (N = 81) | Total (N = 93) |
p-value* | |
|---|---|---|---|---|
| Median (IQR) |
Median (IQR) |
Median (IQR) |
||
| Pre-treatment (per month) | ||||
| Self-Reported household income in USD |
688.0 (574.1–838.5) |
688.0 (442.9–1110.7) |
688.0 (516–1044.9) |
0.828 |
| Intensive Phase (per month) | ||||
| Self-Reported household income in USD |
666.5 (526.8–956.8) |
391.3 (193.5–718.1) |
451.5 (236.5–774.0) |
0.014 |
| Continuation Phase (per month) | ||||
| Self-Reported household income in USD |
741.8 (613.8–924.5) |
193.5 (0.0–430.0) |
236.5 (25.8–559.0) |
< 0.001 |
| End of Treatment (per month) | ||||
| Self-Reported household income in USD |
655.8 (462.3–989.0) |
258.0 (0.0–516.0) |
365.5 (0.0–636.4) |
0.003 |
Estimation of catastrophic costs using the output approach at a 20% threshold
Abbreviation: IQR Interquartile range
*Wilcoxon rank sum test